DLB vs PSA · P/E 28, rev $1.35B vs rev $4.82B
Dolby Laboratories (DLB) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Dolby Laboratories (DLB) is a specialty business services company listed on US.
PSA (PSA) common stock.
Latest reported DLB revenue for 2025-09-26 was $1.35B. Net income was $256.5M. Revenue was up 5.9% from 2024-09-27 to 2025-09-26. DLB currently screens at market cap $7.19B and trailing P/E 28.3.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
DLB currently screens at market cap $7.19B and trailing P/E 28.3. PSA currently screens at market cap $0.
Not investment advice. Open the DLB and PSA stock pages for the full models.
Not investment advice.